Multi-parametric MRI and SPECT Assessment of Treatment Dose and Efficacy in Respect-GBM for recurrent glioblastoma (rGBM) (SNO 2023) - Nov 11, 2023 - Abstract #NIMG-18; Pres time: Nov 18, 2023; 05:05 PM - 05:10 PM; Location: Room 118-120; "Background: We have previously shown a dose-dependent association with survival for patients receiving Rhenium-186-nanoliposome (186RNL) for rGBM... MRI radiographic features proved valuable in assessing treatment efficacy and guiding treatment considerations. Image processing is ongoing, and the complete data set will be presented."
Clinical • Brain Cancer • CNS Tumor • Glioblastoma • Oncology • Solid Tumor
|
|
Shiliang Huang; Andrew J. Brenner; Ande Bao; Joel Michalek; Melissa Moore; Marc Hedrick; Norman LaFrance
|